Ali’s research focuses on the understanding and diagnosis of disease, with a specific interest in cancer. His lectureship will be supported by CAMS for five years, and funding will further his team’s research into high performance liquid chromatography (HPLC) – a gold standard analytical technique that can identify and quantify biomarkers in liquid mixture.
A crucial technology in many industries worldwide, it is hoped that further innovation in HPLC will support its evolution from large, lab-centric machines to low-cost, portable and user-friendly handheld devices or chips.
In collaboration with St Mary’s Hospital, Ali’s research team is currently developing analytical technology for use in liver cancer screening programmes around the world. On the future of the field, he commented:
‘Analytical chemistry is uniquely positioned to drive impact in the areas of healthcare and personalised medicine, but we’re a few rounds of innovation removed to driving lab-standard analyses out into the community. I’m incredibly excited and thankful to CAMS-UK for supporting me. The funding is a significant boost towards realising our ambitions and supports a number of projects that we would otherwise not be able to.’–